Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056600-05
Application #
2097416
Study Section
Radiation Study Section (RAD)
Project Start
1992-04-01
Project End
1998-03-31
Budget Start
1996-05-03
Budget End
1997-03-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
British Columbia Cancer Agency
Department
Type
DUNS #
209137736
City
Vancouver
State
BC
Country
Canada
Zip Code
V5 1-L3
Durand, R E; LePard, N E (2000) Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice. Radiother Oncol 56:245-52
Sham, E; Durand, R E (1999) Repopulation characteristics and cell kinetic parameters resulting from multi-fraction irradiation of xenograft tumors in SCID mice. Int J Radiat Oncol Biol Phys 43:617-22
Sham, E; Durand, R E (1999) Cell kinetics and repopulation parameters of irradiated xenograft tumours in SCID mice: comparison of two dose-fractionation regimens. Eur J Cancer 35:850-8
Durand, R E; Raleigh, J A (1998) Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 58:3547-50
Durand, R E; Sham, E (1998) The lifetime of hypoxic human tumor cells. Int J Radiat Oncol Biol Phys 42:711-5
Huang, P; Olive, P L; Durand, R E (1998) Use of the comet assay for assessment of drug resistance and its modulation in vivo. Br J Cancer 77:412-6
Durand, R E; LePard, N E (1997) Tumour blood flow influences combined radiation and doxorubicin treatments. Radiother Oncol 42:171-9
Durand, R E; Olive, P L (1997) Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice. Radiat Oncol Investig 5:213-9
Durand, R E (1997) Tumor repopulation during radiotheraphy: quantitation in two xenografted human tumors. Int J Radiat Oncol Biol Phys 39:803-8
Durand, R E; LePard, N E (1995) Contribution of transient blood flow to tumour hypoxia in mice. Acta Oncol 34:317-23

Showing the most recent 10 out of 12 publications